Edition:
United States

Beijing Enterprises Medical and Health Industry Group Ltd (2389.HK)

2389.HK on Hong Kong Stock

0.49HKD
26 May 2017
Change (% chg)

HK$-0.03 (-5.77%)
Prev Close
HK$0.52
Open
HK$0.52
Day's High
HK$0.52
Day's Low
HK$0.47
Volume
16,551,000
Avg. Vol
13,317,725
52-wk High
HK$0.60
52-wk Low
HK$0.40

Latest Key Developments (Source: Significant Developments)

Beijing Enterprises Medical And Health Industry Group announces disposal of a subsidiary
Thursday, 13 Apr 2017 10:02am EDT 

Beijing Enterprises Medical And Health Industry Group Ltd <2389.HK> : Unit and purchaser entered into sale and purchase agreement . Consideration for disposal is rmb796.1 million . Vendor conditionally agreed to sell, and purchaser conditionally agreed to purchase, sale interests for consideration .Disposal is expected to realize a net gain of approximately hk$382.7 million for group.  Full Article

Beijing Enterprises Medical And Health Industry Group expects to record a net loss for FY
Wednesday, 15 Mar 2017 08:55am EDT 

Beijing Enterprises Medical And Health Industry Group Ltd <2389.HK> :Group expects to record a net loss for financial year ended 31 december 2016.  Full Article

Beijing Enterprises Medical and Health Industry issues positive profit alert
Monday, 9 Jan 2017 06:11am EST 

Beijing Enterprises Medical and Health Industry Group Ltd <2389.HK> : Anticipates that group will record a consolidated profit for year in financial year 2016 .Anticipated profit is arising form rapid development of group's geriatric and medical segment.  Full Article

Beijing Enterprises Medical and Health Industry bought back on market total of 2.5 mln shares<2389.HK>
Tuesday, 28 Jun 2016 06:45am EDT 

Beijing Enterprises Medical and Health Industry Group Ltd <2389.HK>: Aggregate consideration for the buy-back of shares is HK$1.2 million .Co bought back on market a total of 2.5 million shares.  Full Article

Beijing Enterprises Medical and Health Industry issues profit warning<2389.HK>
Friday, 10 Jun 2016 08:12am EDT 

Beijing Enterprises Medical and Health Industry Group Ltd <2389.HK>: Bj ent m&h-profit warning <2389.HK> . Expects that profit attributable to owners of the co for the six months ended 30 June 2016 may decrease significantly . "Group should record a loss of approximately HK$2 million from continuous operation last year" .  Full Article

Beijing Enterprises Medical and Health Industry says units enter into lease and management agreements<2389.HK>
Monday, 16 May 2016 08:51am EDT 

Beijing Enterprises Medical and Health Industry Group Ltd <2389.HK>: Continuing connected transaction in relation to hospital management agreement and lease agreement <2389.HK> . Beijing yicheng entered into the management agreement with Beijing lianjiao factory and Beijing lianjiao hospital . Beijing lianjiao factory agreed to lease properties for conducting healthcare related business for 5 years . Says Beijing yicheng also entered into lease agreement with Beijing lianjiao factory .  Full Article

ZHONGYUAN UNION CELL & GENE ENGINEERING signs strategic cooperation framework agreement with Beijing Enterprises Medical and Health Industry Group
Wednesday, 21 Oct 2015 08:00pm EDT 

ZHONGYUAN UNION CELL & GENE ENGINEERING CORP., LTD:Signs strategic cooperation framework agreement with Beijing Enterprises Medical and Health Industry Group Limited.To jointly build biological treatment and high-end medical test platform.To set up fund buying specialized hospital.To jointly provide high-end gynecological and obstetric services.  Full Article

Genvon Group Ltd gives H1 2015 loss outlook
Friday, 24 Jul 2015 10:04am EDT 

Genvon Group Ltd:It expects that interim results of group would record a loss for H1 2015.The anticipated loss is mainly because the profit for last year was arouse from a real estate project of the group in Shanghai.  Full Article

Jangho Group signs strategic cooperation framework agreement with Genvon Group
Sunday, 12 Jul 2015 08:00pm EDT 

Jangho Group Co., Ltd:Signs strategic cooperation framework agreement with Genvon Group Ltd on July 12.To form strategic partnership in medical and health area through capital cooperation, resource sharing, capital operation and establishment of 50:50 joint venture with initial capitalization up to HK$100 mln.  Full Article

More From Around the Web

No consensus analysis data available.